The primary goal of cytokine gene therapy is to lessen the toxic side-effects associated with the systemic administration of recombinant cytokines, while achieving the same or higher level of ...
Nanoscale drug delivery vehicles can facilitate multimodal therapies of cancer by promoting tumour-selective drug release. However, few are effective because cancer cells develop ways to resist and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results